2,2,2-trifluoroethyl N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)carbamate, 95.0%, 250mg

4,5-Dimethyl-3-(2-oxo-2-phenylethyl)thiazol-3-ium chloride, 95.0%, 25g

GC capillary column ROTI®Cap-1701, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

5-(Isopropylamino)pentan-1-ol, 97.0%, 1g

(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol, 95.0%, 500g

2-Hydroxy-3-(trifluoromethoxy)benzamide, 98%, 1g

2-Oxo-2-piperazin-1-yl-acetamide hydrochloride, 98.0%, 1g

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 97.0%, 1g

2-Chloro-5-methyl-4-nitropyridine, 95.0%, 250mg

2-Fluoro-6-(4-methylphenylthio)benzonitrile, 1g

Isophthalaldehyde>98.0%(GC)25g

2-Methyl-5-phenyl-thiazole-4-carboxylic acid, 95.0%, 1g

6-(2,2,2-Trifluoroethyl)-1h-thieno[2,3-d]pyrimidine-2,4-dione, 98%, 10g